Last update: Nov. 4, 2018
Minimal risk for breastfeeding and infant.
An antiprotozoal used in the treatment of cryptosporidiosis, giardiasis, intestinal amebiasis, blastocystosis, cutaneous leishmaniasis and microsporidiosis.
Oral administration twice a day for 3 days.
Its pharmacokinetic data - extremely high percentage of protein binding (MK 2014, FDA 2005) and short half-life (Stocks 1996) - explain the negligible transfer to breastmilk observed (Hadad 2012).
Its use is authorized in children from one year of age (Committee 2015, FDA 2005).
Possible side effects are not frequent or serious (abdominal pain, diarrhea, vomiting, headache).
Several experts consider its use to be safe during breastfeeding (Hale 2017 p 710, Briggs 2017, Lactmed 2013).
We do not have alternatives for Nitazoxanide since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine from United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM